Scholars Research Library

Scholars Research Library

A-Z Journals

+44 7389645282

Ava Thomas

Dr, Editorial office, Annals of Experimental Biology, Uxbridge, United Kingdom


  • Opinion   
    Gene therapy for acute lung injury based on non-viral vector delivery
    Author(s): Ava Thomas*

    Acute lung damage is one of the most common types of serious sickness, and despite its high death rate and rapid progression, there is presently no clinically eective treatment for it. he significance of gene therapy in acute lung inury has gron over time as our understanding of the diseases pathological mechanism has deepened. ene therapy for acute lung inury no focuses mostly on improving alveolar fluid clearance, reducing pro-inflammatory response, and mending lung barrier. iral and non-viral vectors are currently used as gene delivery vehicles. hough less efficient than viral vectors, non-viral delivery technologies have the advantages of being less immunogenic, more aordable, and easier to mass-produce. here has been a great deal of research into non-viral delivery systems for gene therapy, including those based on lipids, dendrimers, polymers, graphene, and other inorganic nanop.. Read More»
    DOI: 0

    Abstract HTML PDF

Awards & Nominations

Google Scholar citation report
Citations : 275

Annals of Experimental Biology received 275 citations as per Google Scholar report

Indexed In